{"id":10010,"date":"2020-07-22T11:53:50","date_gmt":"2020-07-22T11:53:50","guid":{"rendered":"https:\/\/en.ennov.com\/?p=10010"},"modified":"2022-05-06T09:42:41","modified_gmt":"2022-05-06T14:42:41","slug":"2020-synairgen-covid-19-clinical-trial","status":"publish","type":"post","link":"https:\/\/dqdev.co\/ennov\/news\/announcement\/2020-synairgen-covid-19-clinical-trial\/","title":{"rendered":"Synairgen Selects Ennov PV to Support COVID-19 Clinical Trial"},"content":{"rendered":"\n

Synairgen has selected Ennov PV to support\nthe conduct of a clinical trial of SNG001 in patients with COVID-19.  Synairgen will be using the Ennov PV Works\nsolution to collect, manage and report clinical safety data associated with the\ntrial.<\/p>\n\n\n\n

\u201cWith COVID-19 impacting so many people\naround the world, Ennov is delighted to be able to continue supporting Synairgen\nin this important study\u201d Says Nic Pillinger, Ennov Pharmacovigilance Director. \u201cOur\naim is to deliver reliable pharmacovigilance tools and services that allow the\nexperts to focus their efforts on such important work.\u201d<\/p>\n\n\n\n

About\nEnnov<\/strong><\/p>\n\n\n\n

Ennov provides the most intuitive, comprehensive,\nand cost-effective suite of software solutions for the life sciences industry.\nFrom leading pharmaceutical companies to emerging biotechnology companies, we\nproudly serve over 200 companies and 150,000 users around the world. Our\nsolutions are designed and built to support the entire Life Sciences R&D\ncontinuum including Clinical, Regulatory, Quality, Pharmacovigilance and\nCommercial.  Ennov is headquartered in\nParis and has offices in the US and UK. For more information about Ennov,\nplease see www.ennov.com<\/a> .<\/p>\n\n\n\n

About\nSynairgen <\/strong><\/p>\n\n\n\n

Synairgen is a respiratory drug discovery\nand development company founded by University of Southampton Professors Stephen\nHolgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on\nlung viral defense in asthma and COPD, uses its differentiating human biology\nBioBank platform and world-renowned international academic KOL network to\ndiscover and develop novel therapies for respiratory disease.  <\/p>\n\n\n\n

Synairgen is conducting a double blind, placebo-controlled clinical trial in COVID-19 patients (SG016). The 220 patient trial comprises 100 patients initiated in hospital and 120 patients to be initiated in the home setting. Synairgen announced positive preliminary results from the hospital setting on 20 July 2020.<\/p>\n\n\n\n

Synairgen is quoted on AIM (LSE: SNG). For\nmore information about Synairgen, please see www.synairgen.com<\/a>\n<\/p>\n","protected":false},"excerpt":{"rendered":"

Synairgen has selected Ennov PV to support the conduct of a clinical trial of SNG001 in patients with COVID-19.  Synairgen will be using the Ennov PV Works solution to collect, manage and report clinical safety data associated with the trial. \u201cWith COVID-19 impacting so many people around the world, Ennov is delighted to be able […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[174,37],"tags":[],"type_content":[],"job":[],"employees_type":[],"class_list":["post-10010","post","type-post","status-publish","format-standard","hentry","category-announcement","category-news","entry"],"acf":[],"yoast_head":"\nSynairgen Selects Ennov PV to Support COVID-19 Clinical Trial<\/title>\n<meta name=\"description\" content=\"Synairgen has selected Ennov PV to support the conduct of a clinical trial of SNG001 in patients with COVID-19.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Synairgen Selects Ennov PV to Support COVID-19 Clinical Trial\" \/>\n<meta property=\"og:description\" content=\"Synairgen has selected Ennov PV to support the conduct of a clinical trial of SNG001 in patients with COVID-19.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dqdev.co\/ennov\/news\/announcement\/2020-synairgen-covid-19-clinical-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"Ennov Software for Life\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-22T11:53:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-06T14:42:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dqdev.co\/ennov\/wp-content\/uploads\/2022\/09\/Ennov-Software-for-Life-Hiring.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ywnent\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@EnnovGroup\" \/>\n<meta name=\"twitter:site\" content=\"@EnnovGroup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ywnent\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/news\\\/announcement\\\/2020-synairgen-covid-19-clinical-trial\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/news\\\/announcement\\\/2020-synairgen-covid-19-clinical-trial\\\/\"},\"author\":{\"name\":\"ywnent\",\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/#\\\/schema\\\/person\\\/e41a11eeaaf9eaa5a5043963e600d44a\"},\"headline\":\"Synairgen Selects Ennov PV to Support COVID-19 Clinical Trial\",\"datePublished\":\"2020-07-22T11:53:50+00:00\",\"dateModified\":\"2022-05-06T14:42:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/news\\\/announcement\\\/2020-synairgen-covid-19-clinical-trial\\\/\"},\"wordCount\":302,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/#organization\"},\"articleSection\":[\"Announcement\",\"Ennov News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/dqdev.co\\\/ennov\\\/news\\\/announcement\\\/2020-synairgen-covid-19-clinical-trial\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/news\\\/announcement\\\/2020-synairgen-covid-19-clinical-trial\\\/\",\"url\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/news\\\/announcement\\\/2020-synairgen-covid-19-clinical-trial\\\/\",\"name\":\"Synairgen Selects Ennov PV to Support COVID-19 Clinical Trial\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/#website\"},\"datePublished\":\"2020-07-22T11:53:50+00:00\",\"dateModified\":\"2022-05-06T14:42:41+00:00\",\"description\":\"Synairgen has selected Ennov PV to support the conduct of a clinical trial of SNG001 in patients with COVID-19.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/news\\\/announcement\\\/2020-synairgen-covid-19-clinical-trial\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dqdev.co\\\/ennov\\\/news\\\/announcement\\\/2020-synairgen-covid-19-clinical-trial\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/news\\\/announcement\\\/2020-synairgen-covid-19-clinical-trial\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Synairgen Selects Ennov PV to Support COVID-19 Clinical Trial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/#website\",\"url\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/\",\"name\":\"Ennov Software for Life\",\"description\":\"Unified Content Management Platform Software for Life Sciences\",\"publisher\":{\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/#organization\",\"name\":\"Ennov\",\"url\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/en.ennov.com\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/ennov-social-graph-1.jpg\",\"contentUrl\":\"https:\\\/\\\/en.ennov.com\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/ennov-social-graph-1.jpg\",\"width\":672,\"height\":672,\"caption\":\"Ennov\"},\"image\":{\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/EnnovGroup\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/81570\\\/admin\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dqdev.co\\\/ennov\\\/#\\\/schema\\\/person\\\/e41a11eeaaf9eaa5a5043963e600d44a\",\"name\":\"ywnent\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1bc4c05f382280b2cd04aea4c2a564edf1c3d002693c3cddb4b8b7982a68bc74?s=96&d=wp_user_avatar&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1bc4c05f382280b2cd04aea4c2a564edf1c3d002693c3cddb4b8b7982a68bc74?s=96&d=wp_user_avatar&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1bc4c05f382280b2cd04aea4c2a564edf1c3d002693c3cddb4b8b7982a68bc74?s=96&d=wp_user_avatar&r=g\",\"caption\":\"ywnent\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Synairgen Selects Ennov PV to Support COVID-19 Clinical Trial","description":"Synairgen has selected Ennov PV to support the conduct of a clinical trial of SNG001 in patients with COVID-19.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Synairgen Selects Ennov PV to Support COVID-19 Clinical Trial","og_description":"Synairgen has selected Ennov PV to support the conduct of a clinical trial of SNG001 in patients with COVID-19.","og_url":"https:\/\/dqdev.co\/ennov\/news\/announcement\/2020-synairgen-covid-19-clinical-trial\/","og_site_name":"Ennov Software for Life","article_published_time":"2020-07-22T11:53:50+00:00","article_modified_time":"2022-05-06T14:42:41+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/dqdev.co\/ennov\/wp-content\/uploads\/2022\/09\/Ennov-Software-for-Life-Hiring.png","type":"image\/png"}],"author":"ywnent","twitter_card":"summary_large_image","twitter_creator":"@EnnovGroup","twitter_site":"@EnnovGroup","twitter_misc":{"Written by":"ywnent","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/dqdev.co\/ennov\/news\/announcement\/2020-synairgen-covid-19-clinical-trial\/#article","isPartOf":{"@id":"https:\/\/dqdev.co\/ennov\/news\/announcement\/2020-synairgen-covid-19-clinical-trial\/"},"author":{"name":"ywnent","@id":"https:\/\/dqdev.co\/ennov\/#\/schema\/person\/e41a11eeaaf9eaa5a5043963e600d44a"},"headline":"Synairgen Selects Ennov PV to Support COVID-19 Clinical Trial","datePublished":"2020-07-22T11:53:50+00:00","dateModified":"2022-05-06T14:42:41+00:00","mainEntityOfPage":{"@id":"https:\/\/dqdev.co\/ennov\/news\/announcement\/2020-synairgen-covid-19-clinical-trial\/"},"wordCount":302,"commentCount":0,"publisher":{"@id":"https:\/\/dqdev.co\/ennov\/#organization"},"articleSection":["Announcement","Ennov News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/dqdev.co\/ennov\/news\/announcement\/2020-synairgen-covid-19-clinical-trial\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/dqdev.co\/ennov\/news\/announcement\/2020-synairgen-covid-19-clinical-trial\/","url":"https:\/\/dqdev.co\/ennov\/news\/announcement\/2020-synairgen-covid-19-clinical-trial\/","name":"Synairgen Selects Ennov PV to Support COVID-19 Clinical Trial","isPartOf":{"@id":"https:\/\/dqdev.co\/ennov\/#website"},"datePublished":"2020-07-22T11:53:50+00:00","dateModified":"2022-05-06T14:42:41+00:00","description":"Synairgen has selected Ennov PV to support the conduct of a clinical trial of SNG001 in patients with COVID-19.","breadcrumb":{"@id":"https:\/\/dqdev.co\/ennov\/news\/announcement\/2020-synairgen-covid-19-clinical-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dqdev.co\/ennov\/news\/announcement\/2020-synairgen-covid-19-clinical-trial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dqdev.co\/ennov\/news\/announcement\/2020-synairgen-covid-19-clinical-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dqdev.co\/ennov\/"},{"@type":"ListItem","position":2,"name":"Synairgen Selects Ennov PV to Support COVID-19 Clinical Trial"}]},{"@type":"WebSite","@id":"https:\/\/dqdev.co\/ennov\/#website","url":"https:\/\/dqdev.co\/ennov\/","name":"Ennov Software for Life","description":"Unified Content Management Platform Software for Life Sciences","publisher":{"@id":"https:\/\/dqdev.co\/ennov\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dqdev.co\/ennov\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/dqdev.co\/ennov\/#organization","name":"Ennov","url":"https:\/\/dqdev.co\/ennov\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dqdev.co\/ennov\/#\/schema\/logo\/image\/","url":"https:\/\/en.ennov.com\/wp-content\/uploads\/2019\/02\/ennov-social-graph-1.jpg","contentUrl":"https:\/\/en.ennov.com\/wp-content\/uploads\/2019\/02\/ennov-social-graph-1.jpg","width":672,"height":672,"caption":"Ennov"},"image":{"@id":"https:\/\/dqdev.co\/ennov\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/EnnovGroup","https:\/\/www.linkedin.com\/company\/81570\/admin\/"]},{"@type":"Person","@id":"https:\/\/dqdev.co\/ennov\/#\/schema\/person\/e41a11eeaaf9eaa5a5043963e600d44a","name":"ywnent","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1bc4c05f382280b2cd04aea4c2a564edf1c3d002693c3cddb4b8b7982a68bc74?s=96&d=wp_user_avatar&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1bc4c05f382280b2cd04aea4c2a564edf1c3d002693c3cddb4b8b7982a68bc74?s=96&d=wp_user_avatar&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1bc4c05f382280b2cd04aea4c2a564edf1c3d002693c3cddb4b8b7982a68bc74?s=96&d=wp_user_avatar&r=g","caption":"ywnent"}}]}},"_links":{"self":[{"href":"https:\/\/dqdev.co\/ennov\/wp-json\/wp\/v2\/posts\/10010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dqdev.co\/ennov\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dqdev.co\/ennov\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dqdev.co\/ennov\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dqdev.co\/ennov\/wp-json\/wp\/v2\/comments?post=10010"}],"version-history":[{"count":0,"href":"https:\/\/dqdev.co\/ennov\/wp-json\/wp\/v2\/posts\/10010\/revisions"}],"wp:attachment":[{"href":"https:\/\/dqdev.co\/ennov\/wp-json\/wp\/v2\/media?parent=10010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dqdev.co\/ennov\/wp-json\/wp\/v2\/categories?post=10010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dqdev.co\/ennov\/wp-json\/wp\/v2\/tags?post=10010"},{"taxonomy":"type_content","embeddable":true,"href":"https:\/\/dqdev.co\/ennov\/wp-json\/wp\/v2\/type_content?post=10010"},{"taxonomy":"job","embeddable":true,"href":"https:\/\/dqdev.co\/ennov\/wp-json\/wp\/v2\/job?post=10010"},{"taxonomy":"employees_type","embeddable":true,"href":"https:\/\/dqdev.co\/ennov\/wp-json\/wp\/v2\/employees_type?post=10010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}